drugset / Trial / NCT00615316

Guaraná for Radiation Related Fatigue in Breast Cancer Patients

NCT00615316 ↗

Phase 2 Completed 36 enrolled Faculdade de Medicina do ABC
RandomizedCrossoverTriple-blindTreatment

Summary

We hypothesize that Guaraná, a native plant from the Amazon, might improve radiation-induced fatigue in breast cancer patients undergoing treatment. In order to assess this, we randomized patients to either guaraná extract or to placebo, switching the assigned treatment mid-term through the radiation.

Timeline

Start
2006-12
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaraná Traditional medicine (herbal / TCM) 75 mg —

Indications

No indication recorded.